Advantage Trust Co Has $352,000 Stake in SPDR S&P Biotech ETF $XBI

Advantage Trust Co raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.4% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 4,245 shares of the exchange traded fund’s stock after acquiring an additional 500 shares during the period. Advantage Trust Co’s holdings in SPDR S&P Biotech ETF were worth $352,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of XBI. Prime Capital Investment Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 37.9% in the second quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock valued at $824,000 after purchasing an additional 2,729 shares in the last quarter. Cerity Partners LLC increased its holdings in shares of SPDR S&P Biotech ETF by 5.8% in the first quarter. Cerity Partners LLC now owns 18,605 shares of the exchange traded fund’s stock valued at $1,509,000 after purchasing an additional 1,016 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 574.5% in the second quarter. Farther Finance Advisors LLC now owns 7,082 shares of the exchange traded fund’s stock valued at $587,000 after purchasing an additional 6,032 shares in the last quarter. N.E.W. Advisory Services LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $95,000. Finally, Investment Partners Asset Management Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 4.0% in the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after purchasing an additional 125 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $110.17 on Tuesday. The firm has a market cap of $6.84 billion, a P/E ratio of 11.47 and a beta of 0.97. The firm has a 50 day simple moving average of $96.56 and a 200 day simple moving average of $86.95. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $110.96.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.